| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 0.06 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.07 |